CRNX logo

CRNX Long Term Liabilities

Annual Total Long Term Liabilities

$52.30 M
+$44.18 M+543.75%

December 31, 2023


Summary


Performance

CRNX Long Term Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCRNXbalance sheetmetrics:

Quarterly Long Term Liabilities

$50.83 M
+$437.00 K+0.87%

September 30, 2024


Summary


Performance

CRNX Quarterly Long Term Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCRNXbalance sheetmetrics:

Long Term Liabilities Formula

Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities

CRNX Long Term Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+543.8%-4.7%
3 y3 years+1195.6%-4.7%
5 y5 years+1502.0%-4.7%

CRNX Long Term Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+1600.4%-4.7%+1552.5%
5 y5-yearat high+1600.4%-4.7%+1552.5%
alltimeall timeat high+1600.4%-46.1%+1552.5%

Crinetics Pharmaceuticals Long Term Liabilities History

DateAnnualQuarterly
Sep 2024
-
$50.83 M(+0.9%)
Jun 2024
-
$50.40 M(-2.1%)
Mar 2024
-
$51.45 M(-1.6%)
Dec 2023
$52.30 M(+543.8%)
$52.30 M(-1.9%)
Sep 2023
-
$53.33 M(+716.9%)
Jun 2023
-
$6.53 M(-11.3%)
Mar 2023
-
$7.36 M(-9.4%)
Dec 2022
$8.13 M(+164.1%)
$8.13 M(-9.2%)
Sep 2022
-
$8.95 M(-5.3%)
Jun 2022
-
$9.45 M(-5.3%)
Mar 2022
-
$9.98 M(+224.6%)
Dec 2021
$3.08 M
$3.08 M(-7.6%)
Sep 2021
-
$3.33 M(-6.8%)
Jun 2021
-
$3.57 M(-6.2%)
DateAnnualQuarterly
Mar 2021
-
$3.81 M(-5.7%)
Dec 2020
$4.04 M(-17.6%)
$4.04 M(-5.3%)
Sep 2020
-
$4.26 M(-4.8%)
Jun 2020
-
$4.48 M(-4.5%)
Mar 2020
-
$4.69 M(-4.3%)
Dec 2019
$4.90 M(+50.0%)
$4.90 M(-4.0%)
Sep 2019
-
$5.10 M(-3.7%)
Jun 2019
-
$5.30 M(-4.6%)
Mar 2019
-
$5.55 M(+70.0%)
Dec 2018
$3.27 M(-89.0%)
$3.27 M(-10.4%)
Sep 2018
-
$3.65 M(-96.1%)
Jun 2018
-
$94.24 M(+1.2%)
Mar 2018
-
$93.17 M(+213.5%)
Dec 2017
$29.72 M(+65.9%)
$29.72 M
Dec 2016
$17.91 M
-

FAQ

  • What is Crinetics Pharmaceuticals annual total long term liabilities?
  • What is the all time high annual total long term liabilities for Crinetics Pharmaceuticals?
  • What is Crinetics Pharmaceuticals annual total long term liabilities year-on-year change?
  • What is Crinetics Pharmaceuticals quarterly total long term liabilities?
  • What is the all time high quarterly long term liabilities for Crinetics Pharmaceuticals?
  • What is Crinetics Pharmaceuticals quarterly long term liabilities year-on-year change?

What is Crinetics Pharmaceuticals annual total long term liabilities?

The current annual total long term liabilities of CRNX is $52.30 M

What is the all time high annual total long term liabilities for Crinetics Pharmaceuticals?

Crinetics Pharmaceuticals all-time high annual total long term liabilities is $52.30 M

What is Crinetics Pharmaceuticals annual total long term liabilities year-on-year change?

Over the past year, CRNX annual total long term liabilities has changed by +$44.18 M (+543.75%)

What is Crinetics Pharmaceuticals quarterly total long term liabilities?

The current quarterly long term liabilities of CRNX is $50.83 M

What is the all time high quarterly long term liabilities for Crinetics Pharmaceuticals?

Crinetics Pharmaceuticals all-time high quarterly total long term liabilities is $94.24 M

What is Crinetics Pharmaceuticals quarterly long term liabilities year-on-year change?

Over the past year, CRNX quarterly total long term liabilities has changed by -$2.49 M (-4.68%)